Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
You must be a Standard 1 Year member to access this content.
Blank Rome advised Novus Capital Corporation on the deal while Gunderson Dettmer represented Energy Vault. Novus Capital Corporation, a publicly traded special purpose acquisition company, or...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Synchronoss on the deal. Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and...
You must be a Standard 1 Year member to access this content.
